Tübingen, Univ., Diss., 2004.

abstract: Breast cancer is the second leading cause of disease related death in women, contributing over 40,000 fatalities annually. The severe impact of breast cancer can be attributed to a poor understanding of the mechanisms underlying cancer metastasis. A primary aspect of cancer metastasis includes the invasion and intravasation that results in cancer cells disseminating from the primary tumor and colonizing distant organs. However, the integrated study of invasion and intravasation has proven to be challenging due to the difficulties in establishing a combined tumor and vascular microenvironments. Compared to traditional in vitro assays, microfluidic models enable spatial organization of 3D cell-laden and/or acellular matrices to better mimic human physiology. Thus, microfluidics can be leveraged to model complex steps of metastasis. The fundamental aim of this thesis was to develop a three-dimensional microfluidic model to study the mechanism through which breast cancer cells invade the surrounding stroma and intravasate into outerlying blood vessels, with a primary focus on evaluating cancer cell motility and vascular function in response to biochemical cues. A novel concentric three-layer microfluidic device was developed, which allowed for simultaneous observation of tumor formation, vascular network maturation, and cancer cell invasion/intravasation. Initially, MDA-MB-231 disseminated from the primary tumor and invaded the acellular collagen present in the adjacent second layer. The presence of an endothelial network in the third layer of the device drastically increased cancer cell invasion. Furthermore, by day 6 of culture, cancer cells could be visually observed intravasating into the vascular network. Additionally, the effect of tumor cells on the formation of the surrounding microvascular network within the vascular layer was evaluated. Results indicated that the presence of the tumor significantly reduced vessel diameter and increased permeability, which correlates with prior in vivo data. The novel three-layer platform mimicked the in vivo spatial organization of the tumor and its surrounding vasculature, which enabled investigations of cell-cell interactions during cancer invasion and intravasation. This approach will provide insight into the cascade of events leading up to intravasation, which could provide a basis for developing more effective therapeutics. / Dissertation/Thesis / Masters Thesis Biomedical Engineering 2017

Abstract In malignancies many alterations involving matrix macromolecule synthesis, secretion and assembly into basement membranes (BMs) as well as their degradation are present. The most important groups associated with matrix turnover are matrix metalloproteinases (MMPs) and their inhibitors (TIMPs). In this study altogether 285 tissue samples were investigated comprising various malignant epithelial tumors and normal tissue structures, in which the distribution of different laminin chains was studied immunohistochemically. Laminin α5, β1 and γ1 were detected almost in all the BMs studied including normal tissues and malignancies, whereas α1 chain of laminin was present only in certain BMs. Laminin γ2 chain was solely expressed by epithelial BMs and was present in intracellular space especially in individual carcinoma cells infiltrating in the tumor stroma and in tumor cells in close contact with BM zone. Generally epithelial tumors contained quite well-formed BMs around their tumor clusters, except for infiltrative breast carcinoma and diffuse type gastric carcinoma. In situ hybridization revealed that only epithelial cells contained mRNAs for laminin α1 and γ2 chains, whereas laminin β1 chain and α1(IV) collagen were synthesized mainly by stromal cells. mRNA for MMP-2 was produced mainly by stromal cells in hepatocellular carcinoma of liver (HCC) and pancreatic adenocarcinoma, whereas MMP-9 and MT1-MMP were equally synthesized by carcinoma cells and cells of tumor stroma. However, in HCCs of grade III carcinoma cells predominated in their MT1-MMP expression. All three MMPs were immunolocalized to malignant epithelial cells and showed variably stromal cell positivity. Statistically mRNA synthesis for MT1-MMP was significantly associated with the shortened survival of patients with HCC (P ≤ 0.01). TIMP-1-3 mRNA, and especially TIMP-3, expressions in normal endometrium were significantly increased in endometrial stromal cells towards the secretory phase. In various endometrial hyperplasias TIMPs and MT1-MMP expressions were quite comparable to those seen in proliferating endometrium. In endometrial adenocarcinomas their expressions were significantly increased and the most intensified mRNA expressions were seen in grade III adenocarcinomas. Especially TIMP-3 and MT1-MMP mRNAs were synthesized by carcinoma cells. The results indicate that epithelial malignancies are capable of active synthesis and assembly of BM macromolecules. Simultaneous matrix synthesis and degradation seen in malignancies suggest that the mechanisms involved in matrix turnover are not lost during malignant transformation. mRNA synthesis for MMPs and TIMPs is generally increased in epithelial malignancies. The results therefore strongly support the concept that MMPs have an active role in carcinoma cell invasion.

Abstract Gelatinases (MMP-2 and MMP-9) play a key role during invasion and metastazising of malignant cells and they have been shown to be associated to invasive phenotype and poor prognosis in several solid tumours. However little is known about their role in hematological malignancies. In the present work, gelatinase expression and its clinicopathological correlations were studied with immunohistochemical staining in 10 cases representing normal bone marrow aspirate smears, 123 cases representing diagnostic bone marrow samples of patients with different leukaemias (35 AML, 7 CLL, 6 CML, 75 ALL), 67 diagnostic paraffin-embedded lymph node biopsies from patients with Hodgkin's lymphoma and 57 biopsies from patients with non-Hodgkin's lymphomas. The lymphoma samples were also stained with factor VIII antibody to evaluate the extent of new vessel formation and the non-Hodgkin's lymphoma cases also with tissue inhibitor of metalloproteinases -1 (TIMP-1) antibody. CLL did not express either of the MMP enzymes, while CML in the chronic phase expressed strongly both of the enzymes. In ALL, gelatinase expression was weak and detectable in pediatric cases in only 12.7% and in the adults in 65% of the cases. In adult ALL, MMP-2 expression correlated strongly with an extramedullary and invasive pattern of disease presentation. In AML MMP-2 positivity had markedly favorable prognostic and predictive power. In lymphoma studies, no correlations could be detected between gelatinase expression and the clinical parameters of invasion. MMP-9 positivity was related to the presence of B symptoms, which difference was statistically significant in Hodgkin's lymphoma. In Hodgkin's lymphoma, strong MMP-9 expression also implicated decreased neovascularization. In both lymphoma types, strong MMP-9 expression correlated with unfavorable prognosis, which difference was statistically significant in non-Hodgkin's lymphomas and remained as a tendency in Hodgkin's lymphoma. MMP-2 had statistically significant association with a favorable prognosis in Hodgkin's lymphoma. Combination of the results of both stainings further increased prognostic power. All together these findings implicate that gelatinases could be used as prognostic tools in AML and lymphomas albeit this needs to be verified in larger materials.

Malaria is a devastating disease that continues to affect millions of people worldwide every year. Specifically, Plasmodium falciparum is the most common human malaria parasite, particularly in sub-Saharan Africa. P. falciparum causes the most malignant and debilitating symptoms with the highest mortality and complication rates. Even with the worldwide efforts of many researchers and organizations, the road to discovering a vaccine has been difficult and challenging. Due do to the improvements in in vitro liver stage assays as well as rodent models of mammalian malaria, pre-erythrocytic stages of malaria have become a more accessible target for experimental studies. These vaccine candidates target Plasmodium sporozoites in the liver and liver stages to prevent development to the blood-stage forms, which is responsible for the debilitating symptoms of the disease. Scanning electron microscopy has been used for decades to provide insight on the morphology and topography of specimens, which cannot be seen through a light microscope. The purpose of this study was to analyze the morphology of sporozoites with some target antibodies. Sporozoites have previously shown uncharacterized appearances and development in an immunofluorescent stain at different concentrations of particular antibodies. With this further understanding on the morphological impact few of the target antibodies have on sporozoites through scanning electron microscopy, further grasp can be acquired.

Various ion channels are expressed in human cancers where they are intimately involved in proliferation, angiogenesis, migration and invasion. Expression of functional voltage-gated sodium (Nav) channels is implicated in the metastatic potential of breast, prostate, colon, cervical and lung cancer cells. However, the cellular mechanisms that regulate Nav channel expression in cancer remain largely unknown. Growth factors are attractive candidates; they not only play crucial roles in cancer progression but are also key regulators of ion channel expression and activity in non-cancerous cells. Here, the role of epidermal growth factor receptor (EGFR) signalling and Nav channels in non-small cell lung cancer (NSCLC) cell lines have been examined. It is shown that functional expression of Nav1.7 promotes invasion in strongly metastatic H460 NSCLC cells. However, in non-invasive A549 NSCLC cells, Nav1.7 is completely absent. Inhibition of Nav1.7 either pharmacologically by tetrodotoxin (TTX) or genetically by small interfering RNA (siRNA) reduces H460 cell invasion by up to 50%. Whilst EGFR signalling enhances proliferation, migration and invasion of H460 cells, EGFR-mediated upregulation of Nav1.7 specifically, is required to promote invasive behaviour in these cells. Examination of Nav1.7 expression at the mRNA, protein and functional levels further reveals that EGFR signalling via the ERK1/2 pathway controls transcriptional regulation of Nav1.7 expression to promote cellular invasion in NSCLC. The role of Nav channels in promoting cancer cell invasion is also unclear. Therefore, the effect of Nav channel activity on two likely downstream contributors to cellular invasion, intracellular calcium concentration, [Ca2+]i, and intracellular pH, pHi, have been examined. It is shown that functional expression of Nav1.7 likely drives H460 NSCLC cell invasion via H+ efflux from the cell in an uncharacterised mechanism potentially involving NHE1, resulting in extracellular acidification of the perimembrane space. However, much more work is needed to understand this Na+-dependent invasive mechanism. Immunohistochemistry (IHC) of patient biopsies confirms the clinical relevance of Nav1.7 expression in NSCLC. Thus, Nav1.7 has significant potential as a novel target for therapeutic intervention, possibly in conjunction with existing EGFR inhibitors, and/or as a diagnostic/prognostic marker in NSCLC.

Les leucémies aigües se caractérisent par une prolifération incontrôlée et par l'augmentation accrue de cellules hématopoïétiques immatures dans la circulation sanguine conduisant à l'infiltration de nombreux organes. Un certain nombre de mécanismes tels que la protéolyse matricielle, l'adhérence cellulaire et l'angiogénèse participent à ce processus d'infiltration extramédullaire et favorisent l'apparition de rechute suite au traitement chimio-thérapeutique. Notre projet s'intéresse à l'éthoxyfagaronine, une benzo(c)phénantridine dérivée de la fagaronine. Au cours de notre étude, nous avons mis en évidence la capacité de l'Etxfag à réduire le potentiel invasif des cellules L1210 impliquant une diminution de l'expression de la MT-MMP à la membrane plasmique ainsi qu'une inhibition du système activateur du plasminogène. Nous mettons également en évidence la capacité de l'Etxfag à diminuer l'adhérence des cellules L1210 au peptide de fibronectine WQPPRARI. Cette diminution implique une déstructuration des radeaux lipidiques empêchant le clustering des intégrines beta1 et leur interaction avec le peptide de fibronectine. Nous montrons également la diminution de l'activation des voies de signalisation dépendantes des intégrines telles que FAK, PYK2 et la PI3-kinase. Notre étude a également porté sur les effets anti-angiogéniques de l'Extfag. Nous montrons la capacité de l'Extfag à réduire l'angiogénèse par l'utilisation de modèle in vitro, ex vivo et in vivo. Cet effet anti-angiogénique semble être lié à une altération des propriétés migratoires des cellules endothéliales. L'ensemble de ces résultats souligne le potentiel anti-leucémique de l'Extfag qui pourrait représenter un nouvel agent chimio-thérapeutique capable de prévenir la dissémination des cellules leucémiques. / Acute leukemias are characterized by uncontrolled proliferation and increased immature hematopoietic cells in the bloodstream leading to the infiltration of many organs. A number of mechanisms such as matrix proteolysis, cell adhesion and angiogenesis are involved in extramedullary infiltration process and promote the appearance of relapse after chemotherapeutic treatment. Our project focuses on the ethoxyfagaronine (Extfag), a benzo(c)phenanthridine derivative of fagaronine. In our study, we demonstrated the ability of the Extfag to reduce the invasive potential of L1210 cells by decreasing MT1-MMP expression to the plasma membrane and by inhibiting the plasminogen activator system. We also demonstrated the ability of Extfag to reduce the adhesion of L1210 cells to fibronectin peptide WQPPRARI. This reduction implies a disorganization of lipid rafts preventing clustering of beta1 integrins and their interaction with fibronectin peptide. We also have shown a decrease of integrin-dependent signaling pathways activation such as FAK, PYK2 and PI3-kinase. We have also studied the anti-angiogenic effects of Extfag. We have shown the ability of the Extfag to reduce angiogenesis by using in vitro, ex vivo and in vivo model. This antiangiogenic effect seems to be related to altered migratory properties of endothelial cells. Taken together, these results highlight the anti-leukemic potential of Extfag which could represent a new chemotherapeutic agent capable of preventing leukemic cells dissemination.

No description available.

Salmonella enterica is a facultative intracellular pathogen, able to invade various hosts and successfully replicate within them. Invasion of polarized cells by S. enterica serovar Typhimurium (STM) occurs in dependence of the type 1 secretion system (T1SS), encoded on Salmonella Pathogenicity Island 4 (SPI4). The 595 kDa non-fimbrial adhesin SiiE is the substrate of the SPI4-T1SS and mediates the first close contact to the host cells apical side. This allows for the type 3 secretion system (T3SS) of the SPI1 to translocate its effector proteins into the host cells cytosol, leading to actin remodeling, membrane ruffle formation and finally uptake of the pathogen. The SPI4-T1SS belongs to the family of ATP-binding cassette (ABC) transporters and is characteristically composed of the ATPase SiiF in the inner membrane (IM), the periplasmic adaptor protein (PAP) SiiD and the secretin SiiC. Further there are two non-canonical proteins encoded, namely SiiA and SiiB, which are known to form a proton channel in the IM. Every single subunit was found to be essential for invasion of polarized cells. The substrate SiiE is transiently retained on the cell surface during secretion process and protrudes the lipopolysaccharide (LPS) layer, a step essential for adhesion. Following translocation of the SPI1-T3SS effector proteins, SiiE is released into the extracellular space. Utilizing a variety of techniques, I was able to show that the transient retention of SiiE only occurs in the outer membrane (OM) protein SiiC and not in the whole two membrane-spanning T1SS. My analyses showed that the proton channel SiiAB is involved in initial steps of secretion and not necessary for release of SiiE, further narrowing down possible modes of action. I found a potential proteolytic cleavage site in the N-terminal part of SiiE, essential for release of the adhesin and discovered a potential retention domain in its N-terminus, too bulky to pass through the secretin. Additionally, I gained first hints that the large cytosolic domain of SiiB is not only involved in SiiE retention mechanism, but also in flagellar-dependent movement under swarming conditions. Using dual-color 3D direct stochastic optical reconstruction microscopy (dSTORM), I was able to localize SiiAB in the IM and SiiB not only at the SPI4-T1SS, but during SiiE retention maximum primarily at the flagellum. Intriguingly, the synthetic expression of siiAB as well as synthetic expression of the flagellar stator unit motAB both showed an increase of velocity. Furthermore, I successfully established murine and human intestinal organoid cell culture for microscopic and quantitative analyses of STM and S. Paratyphi A (SPA) invasion processes. Thus, with this work I was able to reveal new insights of the SPI4-T1SS, its substrate SiiE and the non-canonical subunits SiiAB that pave the way for further SPI4-T1SS investigations and also other secretion systems and their associated subunits.

Exotic annual weeds have transformed western North America, particularly in sagebrush-steppe systems. Restoration of these invaded sites has been met with low levels of success. Pre-emergent herbicide provides a means to control annual weeds, but typically, this treatment does not allow for the concurrent seeding of desired species. Seeding within a deep, U-shaped furrow following herbicide application may be a method to reduce pre-emergent herbicide effects by transferring the herbicide away from the seed at the time of planting. We tested this potential planting technique by spraying plots with or without the pre-emergent herbicide imazapic, and planting bunchgrass seeds either with or without a deep furrow. Treatments (i.e. spraying and furrowing) were applied using mechanical equipment within a single pass, at six sites. In plots without imazapic, we found that deep furrows generally had higher seedling emergence, density of juvenile plants, and above-ground biomass when compared to no furrows. For plots with imazapic, deep furrows also generally improved measured plant metrics for the seeded species compared to plots without furrows. For example, the density of juvenile plants in deep furrows ranged, by study site, between 62% – 97% and 41% – 89% higher than the no furrow treatment, for plots with and without imazapic, respectively. Plots with imazapic and deep furrows was not always as effective as plots without imazapic and deep furrows. Deep furrows also reduced exotic annual weeds in the first year after planting, but weed reduction was generally more effective when this treatment was applied with imazapic. Overall, this research provides evidence that in most instances, the use of deep furrows alone is sufficient to improve seeding success. However, in areas with high weed cover, the application of herbicide followed by the creation of deep furrows in a one-pass system should be considered.